Colvin KJ, Killen HS, Kanter MJ, et al
Any off-label use should be approached cautiously, ideally within clinical trials, and discussed thoroughly with healthcare providers
Ozempic activates the GLP-1 receptors, which results in the promotion of insulin production, suppression of glucagon secretion (a hormone that elevates blood sugar levels), deceleration of gastric emptying, and appetite reduction
Leptin Directly Depolarizes Preproglucagon Neurons in the Nucleus Tractus Solitarius: Electrical Properties of Glucagon-Like Peptide 1 Neurons
[11] [12] These cardiovascular benefits have influenced treatment algorithms, with guidelines recommending GLP-1 receptor agonists with proven cardiovascular benefit for patients with type 2 diabetes and atherosclerotic cardiovascular disease